POC Lipid Testing Market Size by Product Type, Application, End-User, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032
Overview
The POC Lipid Testing Market size was valued at USD 490.28 Million in 2025 and the total POC Lipid Testing revenue is expected to grow at a CAGR of 6.06% from 2025 to 2032, reaching nearly USD 740.13 Million by 2032.
The global POC Lipid Testing Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global POC Lipid Testing Market report also provides trends by market segments, Product Type, and investment with a competitive landscape.
To know about the Research Methodology :- Request Free Sample Report
POC Lipid Testing Market Overview:
Point-of-care testing (POCT) devices are used to screen dyslipidemia and to screen the lipid levels of patients to treat high levels of cholesterol. This test is also used to measure cholesterol, lipid level, triglycerides, low-density lipoprotein, and high-density lipoprotein.
POC Lipid Testing Market Dynamics:
The POC Lipid Testing Market size was valued at USD 490.28 Million in 2025 and the total POC Lipid Testing revenue is expected to grow at a CAGR of 6.06% from 2025 to 2032, reaching nearly USD 740.13 Million by 2032.
The healthcare sector is boosting the market growth of the global market due to growing technological innovations together with biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing a major share of inpatient- point-of-care technologies. An increase in the geriatric population, increasing frequency of Obesity, Cardiovascular and Diabetic diseases, and motivating healthcare awareness are further boosting the market growth.
In Addition, technological advancements, user-friendliness, and accuracy are anticipated to hit the market. Unhealthy and inactive lifestyle habits are anticipated to increase the test rates in the forecast period of 2025-2032. Higher technology, lab automation to offer quick, precise results, together with increased home care amenities with effective diagnostic results is also motivating the growth of the market.
Moreover, the cost of POC testing lipid testing is likely to hamper the growth of the market in the forecast period of 2025-2032. Further, Limited laboratory services with low-skilled professions are estimated to slow the growth of the market.
POC Lipid Testing Market Segment Analysis:
Instrument Sector is Trending in Product Type segment of Global POC Lipid Testing Market.
There are various instruments available for the testing of POC lipids like Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek used for the testing of cholesterol levels in the body are falling under the most used set of instrument for lipid. The market was valued at 189 million in 2025 is likely to grow with a CAGR of 10.7 in the forecast period. New developments in the market and innovation in instruments with the latest technology are fueling the market growth of instrument sub-segment in the forecast period 2025-2032.
Alere Cholestech LDX is the most preferred instrument due to its precise and rapid results. Also, this instrument requires a fewer amount of blood samples and easy to operate on fingertips. Moreover, skilled professions are not required all the time with easy protocol, further, this instrument is widely used for daily homecare testing.
Familial Hypercholesterolemia is considered to supplement the growth of the application segment in the POC Lipid Testing Market.
The global Familial Hypercholesterolemia segment is gaining more attention in the application segment of the market. The major countries dominating in the segment are the USA, Canada, Japan, China, and Europe and are growing with a 2.8% CAGR and accounted for 18% of market share in the forecast period. Familial Hypercholesterolemia is the most common autosomal dominant genetic disease. This disease is characterized by a high level of Low-density lipoprotein cholesterol (LDL-C) and susceptibility to early atherosclerotic cardiovascular diseases.
The hospital sector is anticipated to boost the End-user Segment of the POC-Lipid Testing Market.
The hospital's segment is likely a significant share to gain major market share of the market due to generating awareness in individuals and availability of trained personnel with advanced medical infrastructure. An unhealthy lifestyle and a high-fat diet are growing and resulting in obesity and high cholesterol disorders. Moreover, high population growth with a large number of testing laboratories is further boosting the market growth of the market in the forecast period. Further, hospitals are adopting high technologies for better convenience and rapid results.
POC Lipid Testing Market Regional Insights:
North America is dominating the POC Lipid testing market. The U.S. is a major country and was valued at USD 63.56 Million in the year growing CAGR in the forecast period of 2025-2032. Moreover, the US. Currently holds for 27.03% of market share in the total market. Canada is the second leading country in North America with a growth of 2.3% in the forecast period.
The Asia Pacific is second dominating in the POC-Lipid Testing market. China is leading in the Asia Pacific market due to huge chemical industries and is one of the second-largest economies with a market size of USD 56.8 million with a growing CAGR of 5.7% in the forecast period. Japan is second dominating in the Asia Pacific with a growth of 1.2% in the forecast period.
The objective of the report is to present a comprehensive analysis of the global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global market dynamics, structure by analyzing the market segments and project the global market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.
POC Lipid Testing Market Scope: Inquire before buying
| POC Lipid Testing Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 490.28 Mn. |
| Forecast Period 2026 to 2032 CAGR: | 6.06% | Market Size in 2032: | USD 740.13 Mn. |
| Segments Covered: | by Product Type | Consumables Instruments |
|
| by Application | Hypertriglyceridemia Hyperlipoproteinemia Tangier disease Hyperlipidemia Familial hypercholesterolemia Others |
||
| by End-User | Hospitals Clinical Diagnostic Laboratories Home Care Settings |
||
POC Lipid Testing Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
POC Lipid Testing Market, Key Players:
1. Competitive Assessments
2. Abbott
3. Accriva
4. Agilent Technologies
5. Axis-Shield
6. Beckman Coulter Danaher
7. Becton Dickinson
8. BioData
9. bioMerieux
10. Bio-Rad
11. Cepheid
12. Chrono-Log
13. Corgenix
14. Decode Genetics
15. Diagnostica Stago
16. Diamedix
17. DiaSorin
18. Eiken Chemical
19. EKF Diagnostics
20. Fujirebio
21. Grifols
22. Helena Laboratories
23. Hologic
24. Horiba
25. Instrumentation Laboratory Werfen
26. Kyowa Medex
27. Leica Biosystems
28. Lonza
29. Nihon Kohden
30. Ortho-Clinical Diagnostics
31. Polymedco
32. Qiagen
33. Roche
34. SDIX
35. Sekisui Diagnostics
36. Sequenom
37. Siemens Healthineers
38. Sienco
Frequently Asked Questions:
1. Which region has the largest share in Global POC Lipid Testing Market?
Ans: Asia Pacific region held the highest share in 2025.
2. What is the growth rate of Global POC Lipid Testing Market?
Ans: The Global POC Lipid Testing Market is growing at a CAGR of 6.06% during forecasting period 2026-2032.
3. What is scope of the Global Market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. What was the Global POC Lipid Testing Market size in 2025?
Ans: The Global POC Lipid Testing market was valued at USD 490.28 Mn. In 2025.
5. What is the study period of this Market?
Ans: The Global POC Lipid Testing Market is studied from 2025 to 2032.